Cervical Smear Screening by Pap Smear and Surveillance of HPV Infection among Patients Attending Gynaecology OPD in a Tertiary Care Center - A 12-Months Study
DOI:
https://doi.org/10.21276/apalm.3586Keywords:
Cervical cancer, human papillomavirus, Pap smear, viral DNAAbstract
Background: Cancer of the uterine cervix stands as the 4th most common cancer in terms of incidence and mortality globally. In India, it is the 2nd most common cancer in 2022. Human papillomavirus (HPV) infection is the most common etiological risk factor for cervical cancer, and HPV-16 and 18 are associated with 70% of all invasive cervical cancers.
Methods: A single-centered descriptive study on 111 women was conducted in collaboration with departments of Obstetrics and Gynecology, Pathology and Multi-disciplinary Research Unit (MRU) of a tertiary care center for a period of 12 months, from September 2023 to August 2024. Cervical Pap smear examination by conventional technique and detection of HPV DNA by Hybrid Capture 2 (HC2) system were performed.
Results: One hundred (90.1%) samples were interpreted as Negative for intraepithelial lesion or malignancy (NILM), two (1.8%) samples as Atypical squamous cells of undetermined significance (ASCUS), one (0.9%) sample as Low grade squamous intraepithelial lesion (LSIL) and samples of eight (7.2%) women as Unsatisfactory. HC2 identified 4 (3.6%) hrHPV positive women, out of which three (2.7%) women belonged to the age group of 36 to 45 years. On comparison to Pap smear study, two (50%) were NILM, one (25%) was ASCUS and one (25%) Unsatisfactory.
Conclusion: HPV testing is a well-established screening module for cervical cancer. There is negligible screening of HPV in our state. This study hopes to lay a foundation stone in early screening and prevention of cervical cancer through HPV vaccination in Manipur.
References
1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2024 May;74(3):229-63.
2. World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. World Health Organization; 2020 Dec 31.
3. National Cancer Registry Programme (Manipur): Consolidated reports of Population Based Cancer Registries 2005-2012: Incidence and Distribution of Cancer.
4. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. Journal of clinical pathology. 2002 Apr 1:55(4):244-65.
5. Burd EM. Human papillomavirus and cervical cancer. Clinical microbiology reviews. 2003 Jan;16(1):1-7.
6. Muñoz N. Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papilloma virus types associated with Cervical cancer. N Engl J Med 2003 348;518-27.
7. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlée F, Franco EL. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. New England Journal of Medicine. 2007 Oct 18:357(16):1579-88.
8. Bedell SL, Goldstein LS, Goldstein AR, Goldstein AT. Cervical cancer screening: past, present, and future. Sexual medicine reviews. 2020 Jan;8(1):28-37.
9. American College of Obstetricians and Gynecologists. Updated cervical cancer screening guidelines. Practice Advisory. Washington: American College of Obstetricians and Gynecologists. 2021 Nov 9.
10. Tanne JH. Cervical cancer: US taskforce recommends HPV tests for screening, in updated guidelines. BMJ: British Medical Journal (Online). 2024 Dec 18:387:q2840.
11. Sachan PL, Singh M, Patel ML, Sachan R. A study on cervical cancer screening using pap smear test and clinical correlation. Asia-Pacific journal of oncology nursing. 2018 Jul 1:5(3):337-41.
12. Patel SD, Airao BB. A study of pap smear examination at tertiary care hospital. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2022;11(11):3063.
13. Mishra R, Bisht D, Gupta M. Primary screening of cervical cancer by Pap smear in women of reproductive age group. Journal of Family Medicine and Primary Care. 2022 Sep 1;11(9):5327-31.
14. Nascimento AF, Cibas ES. The ASC/SIL ratio for cytopathologists as a quality control measure: a follow-up study. American journal of clinical pathology. 2007 Oct 1;128(4):653-6.
15. Arrossi S, Temin S, Garland S, Eckert LO, Bhatla N, Castellsagué X, Alkaff SE, Felder T, Hammouda D, Konno R, Lopes G. Primary prevention of cervical cancer: American Society of Clinical Oncology resource-stratified guideline. Journal of global oncology. 201 Oct 3(5):611-34.
16. Mullick R, Sengupta S, Sarkar R, Singh NN, Singh NB, Singh YM, Sarkar K, Chakrabarti S. Genotypic Distribution of Different Variants of Oncogenic Human Papilloma Virus (HPV) among the Sexually Active HIV-1 Positive Female Population from Manipur, India. World Journal of AIDS. 2012 Jun 15:2(2):71-7.
17. Shanker N, Mathur P, Das P, Sathishkumar K, Shalini AM, Chaturvedi M. Cancer scenario in North-East India & need for an appropriate research agenda. Indian Journal of Medical Research. 2021 Jul 1;154(1):27-35.
18. Rai AK, Das D, Kataki AC, Barmon D, Aggarwal D, Deka P. Shrivastava S, Sharma JD, Sarma A, Baruah U, Sharma M. Hybrid capture 2 assay based evaluation of high-risk HPV status in healthy women of north-east India. Asian Pacific Journal of Cancer Prevention. 2014;15(2):861-5.
19. Castle PE, Fetterman B, Poitras N, Lorey T, Shaber R, Kinney W. Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting. Obstetrics & Gynecology. 2009 Mar 1:113(3):595-600.
20. An HJ, Cho NH, Lee SY, Kim IH, Lee C, Kim SJ, Mun MS, Kim SH, Jeong JK. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2003 Apг 1:97(7):1672-80.
21. Jentschke M, Soergel P, Hillemanns P. Evaluation of a multiplex real time PCR assay for the detection of human papillomavirus infections on self-collected cervicovaginal lavage samples. Journal of Virological Methods. 2013 Oct 1;193(1):131-4.
22. Sowjanya AP, Paul P, Vedantham H, Ramakrishna G, Vidyadhari D, Vijayaraghavan K, Laksmi S, Sudula M, Ronnett BM, Das M. Shah KV. Suitability of self-collected vaginal samples for cervical cancer screening in periurban villages in Andhra Pradesh, India. Cancer Epidemiology Biomarkers & Prevention. 2009 May 1;18(5):1373-8.
23. Bhatla N, Dar L, Patro AR, Kumar P. Kriplani A, Gulati A, Iyer VK, Mathur SR, Sreenivas V, Shah KV, Gravitt PE. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?. Cancer epidemiology. 2009 Dec 1:33(6):446-50.
24. Anand KV, Mishra GA, Pimple SA, Biswas SK, Kulkarni VY, Salunke G. Cross-sectional study of HPV self-sampling among Indian women-A way forward. Indian Journal of Medical and Paediatric Oncology. 2022 Feb;43(01):103-8.
25. Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M. Erratum: 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. Journal of lower genital tract disease. 2021 Oct 1:25(4):330-1.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Sucheta Devi Khuraijam, Yengkhom Daniel Singh, Kh. Pratima Devi, Sushma Khuraijam, Robedi Choudhurimayum
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).
